Simulations Plus Hisse

Simulations Plus EBITDA

Simulations Plus (SLP) öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 18 Ağu 2026 itibarıyla -70,73 M USD dir. Önceki yılda, EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) 6,13 M USD idi — -1.253,63% (daha düşük) bir değişiklik.

EBITDA

-70,73 MUSD

YoY

-1.253,63%

Son güncelleme:

Simulations Plus öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 -70,73 M USD dir. Simulations Plus öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2025 6,13 M USD idi. %-1.253,63 daha düşük önceki yıla kıyasla azalmaktadır.
Access this data via the Eulerpool API

Simulations Plus Hisse senedi analizi

Simulations Plus ne yapar? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus, Eulerpool'daki en popüler şirketlerden biridir.

Simulations Plus hisse senedi hakkında sık sorulan sorular

Simulations Plus şirketinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 yılında -70,73 M USD.

Simulations Plus öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 6,13 M USD değerinden -70,73 M USD değerine değişmiş ve bu %-1.253,63 değişimi temsil etmektedir. Değer önceki yıldan daha düşük dir.

Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) öğesinin Simulations Plus değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

EBITDA, finansal yapı, vergi ortamı ve nakit olmayan amortisman giderleri etkisinden önceki işletme performansını ölçer.

EBITDA = EBIT + Amortisman

EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin USD, yatırımcılar için kilit bir faktördür. Bu metrikte yapılan değişiklikler temel faktörlerin iyileşmesini veya kötüleşmesini gösterebilir ve hisse senedi fiyatını doğrudan etkiler. Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin Simulations Plus değerini tarihsel olarak ve gerçek zamanlı olarak takip edebilirsiniz.

Access this data via the Eulerpool API

Gelir Tablosu — Simulations Plus

Tüm Kilit Metrikler — Simulations Plus